Advertisement
Due to the federal government shutdown

FDA Down to 5 Weeks of Funding to Review New Drug Applications

0
Agency cannot accept new fees or applications until the shutdown is over
The rates of complications after invasive diagnostic procedures for lung abnormalities are higher in the community setting than in clinical trials

Complications Higher Than Expected for Invasive Lung Tests

0
Complication rates for invasive lung diagnostic procedures higher than those seen in clinical trials
Cancer patients have an increased suicide risk

Suicide Risk Up More Than Fourfold for Cancer Patients

0
Standardized mortality ratio highest for cancers of lung, head and neck, testes, bladder, Hodgkin lymphoma
Adoption of advanced health information technology capabilities is inconsistent across health care systems

Adoption of Advanced Health IT Capabilities Inconsistent

0
Degree of EHR standardization strongest predictor of health information technology adoption
For cancer patients

Comorbidities Adversely Linked to Cancer Trial Participation

0
Reduction in trial discussions, trial offers, trial participation seen with one or more comorbidities
Ethical principles are discussed in an updated Ethics Manual

American College of Physicians Releases 7th Edition of Ethics Manual

0
Manual focuses on patient-physician relationship in different scenarios, including telemedicine
The influence of heritability and environmental factors has been identified for a large number of phenotypes

Study Explores Influence of Genetics, Environment in Disease

0
Genetic component for 40 percent of phenotypes studied; 25 percent have environmental risk factors
Vitamin D supplementation safely and substantially reduces the rate of moderate-to-severe chronic obstructive pulmonary disease exacerbations in patients with baseline 25-hydroxyvitamin D levels <25 nmol/L

Vitamin D Supplementation Can Help Cut COPD Exacerbations

0
Review shows supplementation only effective for baseline vitamin D levels <25 nmol/L
The median overall survival from diagnosis for patients with stage IV anaplastic lymphoma kinase-positive non-small cell lung cancer is 6.8 years

Median Survival for Stage 4 ALK-Positive NSCLC Nearly 7 Years

0
Most patients in study received crizotinib; prognosis worse when more organs have tumors at diagnosis
The difference in health spending between the United States and other countries is still explained by health care prices

Prices Still Explain High U.S. Health Care Spending

0
Health care prices explain difference in spending between United States and other countries